Chronic medication use and inflammatory skin diseases: The power and limitations of the case-control study

Journal of Investigative Dermatology

Volumn 127, Issue 12, 2007, Pages 2709-2710

  Stern, Robert S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRIC ACID DERIVATIVE;

CASE CONTROL STUDY; CLINICAL PRACTICE; DRUG USE; ECZEMA; ELDERLY CARE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN INFLAMMATION;

EID: 36248974670     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701129     Document Type: Note

References (5)

1. Joly P, Benoit-Corven C, Baricault S, Lambert A, Hellot MF, Josset V et al. (2007) Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study. J Invest Dermatol 127:2766-71
2. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc 287:337-44
3. Kitamura K, Kanasashi M, Suga C, Saito S, Yoshida S, Ikezawa Z (1993) Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions. J Dermatol 20:279-86
4. Morin C, Joly P, Courville P, Young P, Richard C, Balguerie X, Lauret P (2002) Chronic eczematiform eruption in the elderly. Ann Dermatol Venereol 129:19-22
5. Stern R, Khalsa JH (1989) Cutaneous adverse reactions associated with calcium channel blockers. Arch Intern Med 149:829-32